Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer

BACKGROUND: This open-label study evaluated the efficacy and safety of a new leuprolide acetate 45 mg 6-month depot formulation in 151 men with prostate cancer who received 2 intramuscular injections administered 24 weeks apart. METHODS: The primary efficacy measurement was the proportion of patient...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Spitz, A, Young, J M, Larsen, L, Mattia-Goldberg, C, Donnelly, J, Chwalisz, K
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2012
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3278745/
https://ncbi.nlm.nih.gov/pubmed/22025196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pcan.2011.50
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares